AAP News Vol. 13 No. 12 December 1997, p. 2
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aringa, S. D.
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Insulin therapy

Stefanie Dell' Aringa

A new insulin analog could outperform regular insulin for treating certain pediatric patients with insulin-dependent diabetes mellitus (IDDM), according to a New York review.

The new analog lispro, (Humalog®), could improve lifestyles and compliance in patients who are picky or erratic eaters. This new insulin peaks at the same time as absorption of the meal so patients can eat immediately after an injection, the review stated.